These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 16175622)
1. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622 [TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. Honda Y; Yamagiwa S; Matsuda Y; Takamura M; Ichida T; Aoyagi Y J Hepatol; 2007 Sep; 47(3):404-11. PubMed ID: 17448566 [TBL] [Abstract][Full Text] [Related]
4. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis. Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501 [TBL] [Abstract][Full Text] [Related]
5. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760 [TBL] [Abstract][Full Text] [Related]
6. Human monocytoid cells as a model to study Toll-like receptor-mediated activation. Remer KA; Brcic M; Sauter KS; Jungi TW J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029 [TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Raymond CR; Wilkie BN Vet Immunol Immunopathol; 2005 Sep; 107(3-4):235-47. PubMed ID: 15998543 [TBL] [Abstract][Full Text] [Related]
8. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591 [TBL] [Abstract][Full Text] [Related]
9. Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM. Du T; Zhou ZG; You S; Huang G; Lin J; Yang L; Li X; Zhou WD; Chao C Diabetes Res Clin Pract; 2009 Feb; 83(2):208-14. PubMed ID: 19010563 [TBL] [Abstract][Full Text] [Related]
10. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191 [TBL] [Abstract][Full Text] [Related]
11. Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep. Kramer BW; Kallapur SG; Moss TJ; Nitsos I; Newnham JP; Jobe AH Innate Immun; 2009 Apr; 15(2):101-7. PubMed ID: 19318420 [TBL] [Abstract][Full Text] [Related]
12. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104 [TBL] [Abstract][Full Text] [Related]
14. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Mirlashari MR; Lyberg T Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028 [TBL] [Abstract][Full Text] [Related]
15. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362 [TBL] [Abstract][Full Text] [Related]
16. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of Toll-like receptors in chicken heterophils. Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435 [TBL] [Abstract][Full Text] [Related]
18. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969 [TBL] [Abstract][Full Text] [Related]
19. Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Du T; Zhou ZG; You S; Lin J; Yang L; Zhou WD; Huang G; Chao C Clin Chim Acta; 2009 Apr; 402(1-2):133-8. PubMed ID: 19210958 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]